Sodium Phenylbutyrate

Overview

Sodium Phenylbutyrate is a drug used in the treatment of urea cycle disorders, where it acts as an ammonia scavenger to help facilitate the excretion of nitrogen. It is often administered to patients with certain enzyme deficiencies to prevent the accumulation of toxic levels of ammonia in the body.

API suppliers (5)

Suppliers of Sodium Phenylbutyrate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF
• SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF
• SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF
• SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF
• PH HEALTH LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (14 approved US products), the latest listed US patent on Sodium Phenylbutyrate expires 16 Oct 2036. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

decanoate

Canonical SMILES

CCCCCCCCCC(=O)[O-]

InChIKey

GHVNFZFCNZKVNT-UHFFFAOYSA-M

Therapeutic areas